Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Go back to Lineage Cell Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update
(NYSE: LCTX) Delayed: 1.13 +0.05 (4.63%)
Previous Close $1.08    52 Week High
Open $1.10    52 Week Low
Day High $1.16    P/E N/A 
Day Low $1.09    EPS
Volume 1,053,067       

(NYSE: LCTX) Delayed: 1.13 +0.05 (4.63%)
Previous Close $1.08    52 Week High
Open $1.10    52 Week Low
Day High $1.16    P/E N/A 
Day Low $1.09    EPS
Volume 1,053,067